PRNewsWire - Health

Statement from the Alzheimer's Drug Discovery Foundation on the Passing of ADDF Co-Founder and Co-Chairman Leonard A. Lauder
Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Keymed Biosciences gibt die neuesten Ergebnisse der klinischen Studie mit CM336 bekannt, die im New England Journal of Medicine veröffentlicht wurden
Gold Coast Health Plan Denounces Sharing of Medicaid Enrollment Data with Department of Homeland Security